Reviewed by Carola Cornejo
Key Takeaways
- Organ and disease panel codes carry NCCI edits that block separate billing of individual components once the panel’s components have all been performed.
- Modifier 91 applies only to medically necessary repeat testing performed to obtain multiple results on the same day, not to work-arounds for frequency edits.
- Laboratories testing specimens for patients in a covered Part A skilled nursing facility stay must bill the SNF directly, not Medicare, under consolidated billing rules.
- When a referring physician issues an ABN and sends a specimen to an outside lab, the lab needs a copy of that signed ABN before it can bill the patient for a denied test.
Laboratories process claim volumes most physician practices never approach, and laboratory billing errors compound quickly at that scale. A single reference lab can generate thousands of claims a week across chemistry panels, molecular tests, and pathology services. One coding error repeats itself hundreds of times before anyone notices the pattern.
Most laboratory billing errors are not about picking the wrong code entirely. They come from panel logic, modifier application, and payer-specific rules that surface only after a claim is denied or an audit is triggered. The patterns below account for a meaningful share of the denials and clawbacks laboratories see across chemistry, molecular, and pathology testing.
Panel Coding and the NCCI Unbundling Trap
CPT codes 80047 through 80076 define the organ and disease-oriented panels. CMS’s National Correct Coding Initiative requires that when a laboratory performs every component included in one of these panels, it must report the panel code rather than the individual analyte codes. Reporting the components separately when a single panel code applies is unbundling, and NCCI edits are built specifically to catch it. The most frequently confused panels include:
- 80047 — Basic Metabolic Panel (calcium, ionized)
- 80048 — Basic Metabolic Panel (calcium, total)
- 80053 — Comprehensive Metabolic Panel
- 80069 — Renal Function Panel
- 80076 — Hepatic Function Panel
The most common version of this error involves the basic and comprehensive metabolic panels. CPT 80048 (BMP) and CPT 80053 (CMP) share overlapping components, and NCCI treats them as a hard bundling conflict: they cannot be billed together on the same date of service under any circumstances, and no modifier overrides the edit. If both panels were technically run, the correct claim reports the more comprehensive panel only.
The reverse error also happens. If a lab performed only some of a panel’s components, because a test failed, a specimen was insufficient, or the order didn’t call for every analyte, the panel code should not be reported at all. The individual component codes apply instead. Catching this distinction before submission, rather than after a denial, is exactly the kind of check an AI Claim Scrubber is built to run against claim data automatically.
A common example illustrates how the rule works in practice. If a lab individually orders and performs cholesterol, triglycerides, and HDL cholesterol testing, CMS guidance requires the claim to report the lipid panel code (80061) rather than the three individual component codes, because the components performed match the panel definition exactly. If the ordering provider has a medically reasonable and necessary reason to repeat one of those component tests later the same day, that repeat may be reported separately with modifier 91, the same modifier covered in the next section.
Modifier 91 and the Line Between Repeat Testing and Frequency Workarounds
Modifier 91 exists for one specific situation: a laboratory test repeated on the same day because the patient’s clinical condition requires multiple results, not because the original result was unusable. Appropriate and inappropriate uses come down to intent:
- Appropriate: serial glucose checks during a tolerance test, or repeated cardiac enzyme measurements taken to track a clinical trend.
- Appropriate: a physician orders a genuinely new, medically necessary repeat test later the same day based on a change in the patient’s condition.
- Inappropriate: correcting a rejected specimen, an instrument error, or an invalid result — that’s a correction, not a distinct repeat test.
- Inappropriate: appending the modifier to bypass a payer’s frequency limitation on a test.
Modifier 91 is not a substitute for correcting a rejected specimen, and it should never be used to get around a payer’s frequency limitation on a test. Payers watch for exactly this pattern, and repeated modifier 91 use without a clear clinical justification in the record is one of the more common triggers for a targeted audit. The medical necessity for the repeat test needs to be documented in the order or the chart, not just implied by the claim.
Consolidated Billing Blind Spots for SNF Patients
Medicare’s skilled nursing facility consolidated billing rules bundle most ancillary services, including laboratory testing, into the facility’s Part A per-diem payment for a covered stay. When an outside laboratory draws or receives a specimen for a patient in that stay, the lab bills the SNF directly. It does not bill Medicare Part B for that test, even though the lab performed the work and would bill Part B for the same test on a non-SNF patient.
In our work with reference laboratories serving SNF patients, we’ve found that most of these denials trace back to a missing patient status check at intake rather than an actual coding error. A lab may not always know, at the time a specimen arrives, that the ordering source is a Part A SNF stay rather than an outpatient encounter. Billing Medicare directly in that situation results in a payment adjustment and, if the pattern repeats, increased audit attention. Verifying SNF status before the claim goes out, not after a denial comes back, is the more reliable fix.
The ABN Handoff Gap Between Ordering Physicians and Labs
An Advance Beneficiary Notice of Noncoverage can be issued by whichever entity expects Medicare to deny the test, and for lab work, that is often the ordering physician rather than the lab itself. CMS guidance is specific about what happens next: when the notifier issuing the ABN is not the entity that ultimately bills Medicare, meaning a physician collects the specimen and sends it to an outside lab, the physician must give the lab a copy of the signed ABN.
If that copy never reaches the lab, the lab has no valid basis for billing the patient once Medicare denies the claim. The financial liability falls back on the lab rather than transferring to the patient, regardless of whether the physician’s office actually obtained a valid, signed ABN at the time of the visit. This handoff gap is easy to miss because it depends on a workflow between two separate organizations. Confirming medical necessity documentation and diagnosis specificity against a resource like our ICD-10 Code Database at intake helps catch cases where an ABN should have been requested in the first place.
The ABN itself has requirements that trip up busy intake workflows even when the handoff between physician and lab goes smoothly. A valid ABN needs:
- A specific reason for expected non-coverage tied to the exact test in question — medical necessity, a frequency limit, or an experimental service — not a general statement.
- A good-faith cost estimate, which CMS expects to fall within $100 or 25 percent of the actual charge, whichever is greater.
- The patient’s signature and a selected option box, obtained before the test is performed, not after.
A notice missing any of these can be found invalid even when it was otherwise delivered on time, which puts the lab back in the same position as if no ABN existed at all.
Laboratory billing errors like these rarely show up as a single bad claim. They show up as a pattern across thousands of claims, which is what makes them expensive and what makes specialized laboratory billing expertise worth the investment. PGM has supported clinical, reference, and pathology labs for more than four decades, and our team builds billing workflows around how labs actually operate rather than retrofitting general medical billing processes onto lab-specific rules. If your laboratory is looking for a partner who understands panel logic, consolidated billing, and payer-specific documentation requirements from the start, our Laboratory Billing Services webpage outlines how PGM’s team supports labs nationwide. Contact PGM to talk through where your lab’s billing workflow may be leaving revenue on the table.
* * *
Frequently Asked Questions About Clinical Laboratory Billing
Does modifier 91 apply if a test is repeated because the first specimen was rejected or the result was invalid?
No. Modifier 91 is reserved for medically necessary repeat testing to obtain multiple results, such as serial monitoring. A repeat caused by a rejected specimen, an instrument error, or an invalid result is a correction, not a distinct repeat test, and should be documented and billed accordingly rather than appended with modifier 91.
What happens if a laboratory bills Medicare directly for a patient it didn’t know was in a skilled nursing facility stay?
The claim is typically subject to a payment adjustment or recoupment once the SNF stay is identified, since the service falls under that facility’s consolidated billing. Labs that verify patient status at intake, rather than relying on the ordering source to flag it, catch these cases before the claim goes out instead of after a clawback.
What is the QW modifier used for in laboratory billing?
The QW modifier identifies a test performed under a CLIA certificate of waiver, which applies to laboratories authorized to perform only simple, low-complexity testing. Medicare’s Clinical Laboratory Fee Schedule uses QW to determine payment eligibility for waived tests, and omitting it on a claim from a CLIA-waived facility is a common cause of rejection.
How long should a laboratory retain ABN documentation?
CMS guidance calls for retaining the signed ABN for five years from the date of service or discharge, whichever applies. For labs receiving a copy from an ordering physician’s office rather than collecting the signature directly, that retention obligation still applies to the copy on file.
Do NCCI edits ever allow a modifier to override a panel bundling conflict?
Some NCCI edits permit an override with a modifier like 59 when a separate, distinct service is clearly documented. Others are hard edits with no override available, such as the conflict between the basic and comprehensive metabolic panels. Confirming which category an edit falls into, rather than assuming a modifier will resolve it, prevents a denial from turning into a compliance flag.